Contextual Investigation: Monoclonal Antibodies

Authors

  • Swapnil A. Mundhe Shivlingeshwar College of Pharmacy, PharmD, Almala, Tq-Ausa, Dist-Latur, Maharashtra
  • Ashok B. Giri Shivlingeshwar College of Pharmacy, PharmD, Almala, Tq-Ausa, Dist-Latur, Maharashtra
  • Kiran C. Rodge Shivlingeshwar College of Pharmacy, PharmD, Almala, Tq-Ausa, Dist-Latur, Maharashtra

Keywords:

Carrier System, Chemotherapy, Monoclonal Antibodies

Abstract

Monoclonal antibodies (MAb) are antibodies that are indistinguishable in light of the fact that they were created by one kind of insusceptible cell, all clones of a solitary parent cell. The goal of medication focusing on is to convey medications to a particular site of activity through a carrier system. In chemotherapy, cytotoxic medications slaughter carcinogenic cells yet in addition harm typical cells. Monoclonal antibodies produced against explicit antigen, when conjugated to cytotoxic medications, can specifically convey medications to malignancy cells while limiting harm to ordinary cells. Of all the carrier system available, monoclonal antibodies are gaining importance because of their high specificity. There are four basic steps are involved in the production of a monoclonal antibody which are discussed in the following review. Monoclonal antibodies overall address an imperative advancement in clinical medicine therefore purpose of review is to study monoclonal antibodies among all available documents and put forth its brief information to researcher’s.

Downloads

Published

2020-08-30

How to Cite

Swapnil A. Mundhe, Ashok B. Giri, & Kiran C. Rodge. (2020). Contextual Investigation: Monoclonal Antibodies. World Journal of Pharmaceutical Sciences, 8(9), 179–186. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/contextual-investigation-monoclonal-antibodies

Issue

Section

Review Article